0001209191-23-047522.txt : 20230828
0001209191-23-047522.hdr.sgml : 20230828
20230828163924
ACCESSION NUMBER: 0001209191-23-047522
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230828
FILED AS OF DATE: 20230828
DATE AS OF CHANGE: 20230828
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Loerop James
CENTRAL INDEX KEY: 0001781549
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37581
FILM NUMBER: 231216488
MAIL ADDRESS:
STREET 1: C/O ACLARIS THERAPEUTICS, INC.
STREET 2: 640 LEE ROAD, SUITE 200
CITY: WAYNE
STATE: PA
ZIP: 19087
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Aclaris Therapeutics, Inc.
CENTRAL INDEX KEY: 0001557746
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 460571712
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 640 LEE ROAD
STREET 2: SUITE 200
CITY: WAYNE
STATE: PA
ZIP: 19087
BUSINESS PHONE: 484-324-7933
MAIL ADDRESS:
STREET 1: 640 LEE ROAD
STREET 2: SUITE 200
CITY: WAYNE
STATE: PA
ZIP: 19087
4
1
doc4.xml
FORM 4 SUBMISSION
X0508
4
2023-08-28
0
0001557746
Aclaris Therapeutics, Inc.
ACRS
0001781549
Loerop James
C/O ACLARIS THERAPEUTICS, INC.
640 LEE ROAD, SUITE 200
WAYNE
PA
19087
0
1
0
0
Chief Business Officer
0
Common Stock
2023-08-28
4
P
0
14705
6.7976
A
21688
D
The price reported is a weighted average purchase price. The shares were purchased in multiple transactions at prices ranging from $6.7699 to $6.80, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
/s/ Mark Ballantyne, Attorney-in-Fact
2023-08-28